Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Keros Therapeutics (KROS) over the last 6 years, with Q3 2025 value amounting to 0.33.

  • Keros Therapeutics' Asset Utilization Ratio rose 2603287.73% to 0.33 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33, marking a year-over-year increase of 2603287.73%. This contributed to the annual value of 0.01 for FY2024, which is 151390.47% up from last year.
  • As of Q3 2025, Keros Therapeutics' Asset Utilization Ratio stood at 0.33, which was up 2603287.73% from 0.3 recorded in Q2 2025.
  • Keros Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.33 during Q3 2025, with a 5-year trough of 0.0 in Q1 2021.
  • For the 5-year period, Keros Therapeutics' Asset Utilization Ratio averaged around 0.09, with its median value being 0.01 (2024).
  • In the last 5 years, Keros Therapeutics' Asset Utilization Ratio crashed by 10000.18% in 2021 and then surged by 387010385.41% in 2022.
  • Keros Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.07 in 2021, then fell by 13.25% to 0.06 in 2022, then tumbled by 99.33% to 0.0 in 2023, then surged by 1269.64% to 0.01 in 2024, then soared by 5437.6% to 0.33 in 2025.
  • Its Asset Utilization Ratio was 0.33 in Q3 2025, compared to 0.3 in Q2 2025 and 0.31 in Q1 2025.